Adapthealth Corp (AHCO) support and resistance · P/E 16, rev $1.42B
Adapthealth Corp (AHCO) is a medical devices company listed on US.
This page maps Adapthealth Corp (AHCO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AHCO revenue for 2026-06-30 was $1.42B. Net income was -$150.0M. Revenue was up 73.2% from 2026-03-31 to 2026-06-30. AHCO currently screens at market cap $1.26B and trailing P/E 16.1.
AHCO currently screens at market cap $1.26B and trailing P/E 16.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AHCO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AHCO quote page for the session range and the stock page for the full model.
Not investment advice.